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THE RELATIONSHIP OF INSIGHT TO 
PSYCHOPATHOLOGY IN SCHIZOPHRENIA: A 
CROSS-SECTIONAL STUDY 
VIMAL M.AGA, A.K.AGARWAL, S.C.GUPTA 
Insight plays an important rote in the management of Schizophrenia. The study was undertaken to 
assess the cross-sectional relationship of clinical variables andpsychopathology to insight, using the 
BPRS and the Insight Schedule. The study sample consisted of 59ICD-10 Schizophrenics with a mean 
duration of illness of 41.88 months. Insight was found to have significant positive association with 
number of previous episodes of illness and treatment taken in the past. The correlation matrix of BPRS 
total score with InsightScheduleitem scoresrevealednon significantnegative correlations. On multiple 
regression analysis, psychopathology was found to explain significantly about a third of the variability 
in insight, thus demonstrating only partial dependence of insight on psychopathology. Construct 
analysis of the Insight Schedule was undertaken in parallel to th.* main study and revealed a component 
structure similar to that espoused by its author, ensuring comparability between the present and 
previous studies. 
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INTRODUCTION 
Insight has been variously defined in psychiatry 
(Carpenter et al, 1973; Heinrichs et al, 1985; Mc-
Evoy et al, 1981). Freud (1933) supported the view 
that insight refers to a genuine awareness of uncon-
scious conflicts or drives (cited in David, 1990a). 
Other concepts of insight were put forward by the 
phenomenological school (Jaspers, 1913) and the 
Gestalt psychologists (cited in Hare & Lamb, 1983). 
The Comprehensive Textbook of Psychiatry 
(Kaplan & Sadock, 1989) defines insight as the 
"degree of awareness and understanding the patient 
has that he or she is ill", but in their subsequent 
grading of insight, evidence of the psychoanalytic 
roots of the concept can be seen in words like'denial' 
(grade 1) and 'emotional insight' (grade 6). 
With growing research into the issue, consensus 
is emerging that insight is not a unidimensional 
concept (David, 1990b; Amador et al, 1993). Thus 
the older studies such as the International Pilot Study 
of Schizophrenia (IPSS: WHO, 1973), which had 
rated insight on the basis of a dichotomous concept 
may not be very valid today with respect to insight. 
The recent realization that the "component dimen-
sions of insight are continuous...one can have partial 
insight" (Amador et al, 1993), is in keeping with the 
concept of six grades of insight (Kaplan & Sadock, 
1989). 
Till a few years ago, measurement of insight, in 
view of the above, was highly unsatisfactory. 
Though insight has, since a long time, been regarded 
as an important part of the Mental State Examination 
(Kaplan & Sadock, 1989; Appleby & Forshaw, 
1990), drawbacks in its assessment included lack of 
an operational definition and standardized measure-
ment procedures (David et al, 1992). A common 
method of measurement was through the use of the 
PSE-9 (Wing et al, 1974) item 104, eg. the IPSS 
(WHO, 1973). However, there has been a recent 
spurt of structured insight measurement schedules, 
in keeping with the recent revival of interest in this 
issue (Amador et al, 1991). Three recently con-
structed insight rating instruments are the Insight 
and Treatment Attitudes Questionnaire (ITAQ: Mc-
Evoy et al, 1989a), the Insight Schedule (David, 
1990a) and the Scale to Assess Unawareness of 
Mental Disorder (Amador et al, 1993). 
Insight level can vary across the many manifes-
tationsof illness (Amador etal, 1993), i.e., there may 
be awareness of only one aspect of illness. Insight 
changes with the course of illness, but the direction 
of change is uncertain: some report an increase in 
the insight of schizophrenics with symptomatic im-
provement (Small et al, 1965 a & b) others have 
shown insight to decrease (Whitman & Duffey, 
1961), while yet a third group reported lack of con-
sistent direction of change in insight with improve-
ment in psychopathology (McEvoy et al, 1989a). 
McEvoy et al (1989a) found significant moderate 
inverse correlation between ITAQ and BPRS and 
CGI scores only at day 14, and between only ITAQ 
and CGI scores at final assessment (in keeping with 
the changing nature of insight). In a companion 
study, the authors report an association between VJtf.AGAETAL 
insight scores and lower readmission rates (upto 3 
1/2 years follow up). A significant trend for patients 
with more insight to be compliant with treatment 
thirty days after discharge was also reported (Mc-
Evoy et al, 1989b). A moderate inverse correlation 
between one year follow up ITAQ scores and BPRS 
total score and BPRS measure of psychoses was 
found in another prospective study of 25 
schizophrenics (22 of which were assessed after the 
first year), only the latter of which was statistically 
significant (McEvoy et al, 1993). 
A consistent negative correlation between BPRS 
scores and the scores of David's Insight Schedule 
were found to be statistically significant only after 
week two in a mixed sample of eight schizophrenics 
and fourteen affective disorder patients (Kulhara et 
al, 1992a). Another study of ninety one mixed 
psychotic patients diagnosed by the PSE/CATEGO 
system (David et a I, 1992), showed no significant 
difference in insight between the 52 S+ (definitely 
schizophrenic) and the other 39 patients. On the 
other hand, Kulhara et al (1992b) reported sig-
nificantly better insight in the affective disorder 
patients at initial assessment as well as significantly 
better improvement acrose time than in the 
schizophrenic group. 
The present study was therefore undertaken to 
assess the cross-sectional relationship of clinical 
variables and psychopathology to insight in a 
homogeneous diagnostic groups of ICD-10 
schizophrenics and to ascertain the amount of the 
variability in insight that can be satisfactorily ex-
plained by psychopathology alone. A parallel aim 
was to undertake a construct analysis of the Hindi 
adaptation of David's Insight Schedule, which was 
the insight assessment instrument used in the study. 
MATERIALS AND METHODS 
Subjects for this study were selected from con-
secutive admission on specified beds to the adult 
psychiatry unit, King George's Medical College 
(KGMC), Lucknow, fulfilling the following selec-
tion criteria: an ICD-10 diagnosis of Schizophrenia 
(WHO, 1992), age of the patient between 17 to 65 
years, and consent for the study from the patients and 
their relatives. 
Those with a comorbid neurological or 
psychiatric disorder were excluded from the study. 
The study had an open cross-sectiona) design. Tools 
of assessment included: 
1. Brief Psychiatric Rating Scale (BPRS: 
Overall & Gorham, 1962) 
A modified 18 item version of the original 16 
item scale has been in use since the late sixties, and 
was used in the study. It is rated on a seven point 
scale (Been et al, 1986). The scoring also yields 5 
factor scores, anxiety-depression, thought distur-
bance, anergia, hostile-suspiciousness and activa-
tion (cited in Hafkenscheid, 1991) while 10 items 
can be combined to yield a schizophrenia subscale. 
The total scores are added to yield three syndrome 
levels: no syndrome (0-14), minor syndrome (15-
29), and major syndrome (more than 29) (Been et al, 
1993). It has been shown to have excellent 
reliability, validity, and sensitivity to change (Hed-
lund&Vieweg, 1980). 
2. Insight Schedule (IS: David, 1990a) 
This is a short scale comprising of 3 subscales and 
one supplementary question. It is based on the con-
cept that insight is based on three different but 
overlapping constructs - ability to relabel unusual 
mental events as pathological (scored 0-4), recogni-
tion by the patient of the presence of mental illness 
(scored 0-6), and treatment compliance, both ex-
pressed and observed (score 0-4). A supplementary 
question assesses hypothetical contradiction (scored 
0-4). A supplementary question assesses hypotheti-
cal contradiction (scored 0-4) (Brett-Jones et al, 
1987), thus bringing the maximum possible score to 
18 (range 0-18). Psychometric properties of this 
scale have since been reported (David et al, 1992). 
In a prelim inary study in India, the scale was used 
without the supplementary question, and was shown 
to be satisfactory (Kulhara et al, 1992a). This was 
one major reason for selecting this instrument for use 
in this study, over the other recent insight rating 
scale. The scale has been subsequently expanded to 
include items on awareness of change (David & 
Kemp, 1994; personal communication) but since the 
psychometric properties of this version have not yet 
been reported, this version was not taken up for use 
in the study. The authors adapted ihe entire scale into 
Hindi prior to use in the study. The construct analysis 
of this Hindi version was undertaken simultaneously 
with the main study. 
The procedure, briefly, was as follows. Prior 
education regarding the illness was provided to all 
patients from a standardized information sheet con-
structed in simple Hindi. It was further ensured that 
^11 patients were admitted under one consultant 
(AKA) and were rated by a single author (VMA) to INSIGHT AND PSYCHOPATHOLOGY 
minimize variability in the assessment procedure. 
Each patient was first seen together with the atten-
dant and the nature of the study was explained to 
them, to allay the anxiety of the patients. Patients 
were then told, "I am going to ask you a few ques-
tions that will assess your symptoms and motivation 
for treatment". Sociodemographic data was noted in 
a semi-structured proforma and patient were then 
rated on the BPRS and the Insight Schedule con-
secutively. 
Statistical analysis was done according to the 
principles outlined by Glantz and Slinker (1990) and 
Altmann (1992). The analyses were carried out 
using the EPI-INFO and MINITAB statistical 
software packages. Tests were considered sig-
nificant at p<0.05. Two-tailed p values were used 
throughout. Fisher's Exact Test was used for fre-
quency data and Student's t test for continuous data. 
Adjustments were made in the alpha error value for 
the correlation metrics using the Bonferroni correc-
tion (Grove & Andreasen, 1982). Backwards multi-
ple regression was used in the study, with a 
backwards F-to-remove of p>0.05. Since it was 
decided to enter only n/10 variables into the regres-
sion model, only those BPRS items found significant 
on linear regression at p<0.03 were entered into the 
multiple regression equation. 
RESULTS 
A total of 82 patients clinically diagnosed as 
schizophrenia were screened for inclusion in the 
study. Nine patients did not meet the ICD-10 F20 
criteria for Schizophrenia and were excluded, as 
were those with a neurological (1) or psychiatric (8) 
comorbidity. Five patients could not be immediately 
assessed as they were uncooperative, and either 
absconded or were discharged against medical ad-
vice before revaluation. A total of 23 patients were 
thus excluded, and the final analysis was carried out 
on 59 subjects. 
The mean age of this study sample was 35.44 
years (SD=10.45; range 18-55 years), 64.41% of the 
sample being male. Mean duration of illness was 
41.88 months and there were 33 (55.93%) first 
episode patients. There were 31 paranoid 
schizophrenics (52.54%), 4 hebephrenic 
schizophrenics (6.78%), 4 catatonic schizophrenics 
(6.78%) and 20 undifferentiated schizophrenics 
(33.9%). The mean BPRS score was 31.22 
(SD=6.99) and the mean Insight Schedule score was 
4.91 (SD-3.98), the latter being less than 33% of the 
maximum possible score. Patients were receiving a 
mean of 659.60 mg chlorpromazine or equivalents 
(SD=495) and 4.44 mg trihexyphenidyl (SD=3.30). 
Thirteen patients were receiving benzodiazepines 
(22.03%), 5 were on depot neuroleptic (8.47%) and 
3 had received ECT (5.08%) a minimum of 1 week 
prior to assessment. 
Table 1 
Association of clinical variables with Insight 
1. Duration of illness 
.(1 year vs. others) 
2. Episode (1st. vs. others) 
3. Subtype (F 20.2 vs. Others) 
Fisher's Exact 2-tailed 
p=0.2863 
Fisher's Exact 2-tailed 
p=0.0328* 
Fishers's Exact 2-tailed 
p=1.0000 
4. Current treatment 
-Chlorpromazine/equivalent (mg.) Two-sample t= 1.10, 
df=57 p=0.33 
-Trihexyphenidyl (mg.) Two-sample t=0.04, 
df=57.p=0.97 
-Benzodiazepines Fisher's Exact 2-tailed 
(received vs.not received) p=1.0000 
-ECT (received vs. not received) Fisher's Exact 2-tailed 
p=1.0000 
•Depot injectables Fisher's Exact 2-tailed 
(received vs.not received) p=1.0000 
5. Past treatment Fisher's Exact 2-tailed 
(received vs. not received) p=0.0449 * 
6. BPRS syndrome Fisher's Exact 2-tailed 
(Major vs.others) p=0.5983 
* significant at p<0.05 
Since no cut-off score has been provided by its 
author for rating patients as having high and low 
scores on the Insight Schedule, the rather arbitrary 
procedure followed by McEvoy et al (1989b) with 
the ITAQ was followed. The sample was divided 
into these with high and low scores on the Insight 
Schedule, using 66% of the maximum score or 
above as the cut-off point. Clinical variables were 
compared between the two groups (Table 1). 
Patients who scored 66% of the maximum score of 
higher on the Insight Schedule had significantly 
more number of past episodes (p<0.05) and were 
significantly more likely to have had received treat-
ment in the past (p<0.05). On the other hand, no 
significant inter-group differences were found on 
possible confounding variables: age,sex, education 
and family type. 
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Correlation matrix of the items of the Insight Schedule 
and BPRS total scores (n=59) 
BTOT 11 12 " 13 14 
Ti -0.404 
12 -0.174 0.584* 
13 -0.162 0.342 0.454* 
14 -0.160 0.421* 0.644* 0.554* 
HOT -0.284 0.756* 0.886* 0.701* 0.807* 
The alpha-overall for the matrix is significant at p<0.05, 
hence the critical p-value of Pearson's r (Bonferroni 
correction) is 0.0033. 
* Significant at p<0.0033 
Table 3 
Regression of BPRS item scores on Insight Schedule 
total scores 
The Regression equation is 
ITOT = 9.28 + 1.40 B5 - 0.782 B14 - 0.571 B15 
Predictor Coef Stdev t-ratio p VIF 
Constant 9.277 1.235 7.51 0.000 
B5 1.3959 0.5735 2.43 0.018 1.1 
B14 -0.7819 0.2550 -3.07 0.003 1.1 
B15 -0.5714 0.2655 -2.15 0.036 1.0 
s = 3.322 R-sq = 33.9% R-sq(adj)= 30.3% 
Analysis of Variance: 
Source DF SS MS F P 
Regression 3 311.75 103.92 J.42 0.000* 
Error 55 606.83 11.03 
Total 58 918.58 
* Significant at p<0.001 
The correlation matrix between the various items 
and the total (ITOT) of the Insight Schedule and the 
total BPRS (BTOT) scores is reproduced in Table 2. 
There were low negative correlations between 
BTOT and all items of the Insight Schedule, which 
were not statistically significant at the adjusted alpha 
error value. 
The standardized scores of 6 BPRS items were 
entered into the multiple regression equation, the 
outcome variable being Insight Schedule Total score 
(ITOT"). The predictor variables were Guilt Feeling 
(B5;l p=0.004). Hostility (BIO; p=0.005), Un-
coopcrativeness (B14; p=0.000). Unusual Thought 
Content (B15; p=0.024). Disorientation (Bl8; 
p=0.024) and Total BPRS Score (BTOT; p=0.029). 
Interaction between items was not studied. Back-
wards regression yielded the final three-variable 
model (Table 3). The model was able to explain 
significantly 30.3% of the variance in insight (p< 
0.001). The Variance Inflation Factors (VIF: Table 
3) of all the variables indicated no serious multicol-
Iinearitly, and normal plot of the residuals (not 
shown) revealed no significant departures from nor-
mality. The three BPRS items in the final model 
were Guilt feeling, Uncooperativeness, and Unusual 
thought content. 
Table 4 
Principal components analysis of the Insight Schedule 
VARIABLE PCI PC2 PC3 PC4 PC5 
li 0396 O660 0.472 0.338 0.264 
12 0.464 0.208 -0.383 -0.687 0.350 
13 0.385 -0.659 0.588 -0.156 0.219 
14 0.442 -0.291 -0.533 0.621 0.223 
ITOT 0.533 0.046 0.001 -0.056 -0.843 
Eigen value 3.5072 0.7094 0.4777 0.3050 0.0007 
proportion(%) 
Cumulative 70.1 14.2 9.6 6.1 0.0 
proportion^) 70.1 84.3 93.9 100.00 100.00 
The construct analysis of the Hindi Insight 
Schedule was simultaneously undertaken. All inter-
correlations between items and the total score of the 
Insight Schedule were significant at the adjusted 
alpha level (Table 2) except the correlation between 
Insight Schedule items 1 (Compliance) and 3 
(Relabelling of Psychosis). The principal com-
ponents analysis of the Insight Schedule (Table 4) 
yielded a single com ponent accounting for 70.1 % of 
the variance. The rest of the com ponents, in descend-
ing order, accounted for 14.2%, 9.6% and 0% of the 
variance respectively. The highest item loading on 
the first principal component was for the total score 
(0.533) and the lowest for relabelling of psy -hosis 
(0.385). This indicates that the IS total score can 
function well as a single composite measure of in-
sight. 
DISCUSSION 
The present study was undertaken to assess the 
cross sectional relationship of psychopathology to 
insight in schizophrenia (ICD-10). A single diagnos-
tic group was taken up for study since previous work 
indicates that insight in schizophrenia (rated on the 
Insight Schedule) differs significantly from that in 
other diagnostic groups (Kulhara et al, 1992b). A INSIGHT AND PSYCHOPATHOLOGY 
recent study published after the completion of the 
present one used the ITAQ and reported similar 
findings (Michalakeas et al, 1994). There was no 
association between insight and demographic vari-
ables, as also observed in previous studies (Kulhara 
et al, 1992a; David et al, 1992). Unlike these pre-
vious studies, two clinical variables, number of pre-
vious episodes and treatment taken in the past, were 
significantly positively associated with insight 
scores. It has been suggested (Amador et al, 1993) 
that insight may depend upon the information 
provided during past episodes. This study did not 
assess if there had been any formal attempts to 
educate these patients about their illness in the past. 
However, treatment (with or without hospitaliza-
tion) undeniably includes some exposure to infor-
mation about the illness, which may result in the 
significantly improved insight in the subsequent 
episodes. 
It was imperative to undertake a construct 
analysis of the Insight Schedule because a Hindi 
adaptation of David's original scale was used in the 
study. Significant positive correlations were ob-
served between all the items and total score expect 
Compliance (item 1) and Relabelling of psychosis 
(item 3). A similar analysis of this instrument has 
been undertaken in only one previous study (Kul-
hara et al, 1992a), apart from the data published by 
the author of the original scale (David et al, 1992). 
Our findings were closer to those of the later study. 
The principal components analysis in the present 
study yielded a single factor solution, again similar 
to the data reported by David et al (1992), but the 
item loading on this factor was different in the 
present study. A component analysis of this scale 
was not reported by Kulhara et al (1992 a& b). Taken 
together, these findings indicate the robustness of 
the Insight schedule as an assessment instrument 
across different populations and ensure com-
parability between the present and previous studies. 
The BPRS total score had low, inverse (non-sig-
nificant) correlations with Insight Schedule items 
and total score, as in most studies (initial scores in 
the studies of McEvoy et al, 1989; McEvoy et al, 
1993; Kulhara et al, 1992a and most recently, 
Michalakeas et al, 1994). 
In insight completely independent of 
psychopathology in schizophrenia? Multiple regres-
sion analysis suggests that less than a third of the 
variability in insight can be significantly explained 
by psychopathology alone. This was the single most 
important finding of this study and no comparable 
work could be found. Interestingly, the regression 
equation indicates that an increase in guilt feeling 
leads to better insight. One explanation for this ob-
servation may be that both increase in insight and 
increase in quilt feeling, are concomitant of im-
provement in psychopathology. 
It is difficult to say at present what variables may 
explain the other 70% of the variability in insight. 
Since the aim of the study was to assess only the 
contribution of psychopathology to insight, only 
BPRS item scores were entered into the regression 
model. However, other factors that could further 
explain some of the variability in insight include 
formal patient education about their illness (Amador 
et al, 1993), the patients' IQ (David et al, 1992), the 
attitude of the family towards mental illness, and 
general awareness of mental illness in the com-
munity, but to date these have probably not been 
assessed for their contribution to insight. 
Two drawbacks of this study require some 
elaboration. Firstly, the single point assessment pro-
cedure ignored the dynamic aspects of both 
psychopathology and insight, but the cross-sectional 
relationship was readily apparent, w hich was the aim 
of the study. Secondly, the stringent level for selec-
tion of variables to enter into the regression model 
(p<0.03), necessitated by the limitations of the 
sample size, lead to slight increase in the type II error 
rate. However this did not decrease the amount of 
variance explained by the final model; in fact, the 
full six variable model could explain only 27.5% of 
the variance (p=0.001). 
Since poor insight plays an important role in the 
management of schizophrenia, it is particularly im-
portant to study the factors that contribute to insight. 
The present study found that while more number of 
previous episodes and treatment taken in the past 
significantly increased insight in the subsequent 
episodes, psychopathology along accounted for less 
than a third of the variability in insight. A study of 
other variables proposed may go a long way in 
unraveling this complex clinical phenomenon. 
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